Los Angeles, CALIFORNIA4 Active Studies

Scleroderma Clinical Trials in Los Angeles, CALIFORNIA

Find 4 actively recruiting scleroderma clinical trials in Los Angeles, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,031
Enrolling

Recruiting Scleroderma Studies in Los Angeles

RecruitingLos Angeles, CALIFORNIANCT06195072

Platform Clinical Study for Conquering Scleroderma

The goal of this clinical trial is to test efficacy of different investigational products (IPs) compared with placebo on the change from baseline to the end of the treatment period at Week 52 in lung ...

400 participants
Scleroderma Research Foundation, Inc.
View Study Details
RecruitingLos Angeles, CALIFORNIANCT05925803

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus placebo in adult participants with systemic sclerosis. The target population for this...

306 participants
AstraZeneca
View Study Details
RecruitingLos Angeles, CALIFORNIANCT05878717

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

This study investigates the efficacy and safety of belimumab compared to placebo, in addition to standard therapy, for the treatment of participants with systemic sclerosis associated interstitial lun...

300 participants
GlaxoSmithKline
View Study Details
RecruitingLos Angeles, CALIFORNIANCT05892614

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

This is a 2-Part study with Part A, a double-blind, randomized, placebo-controlled, PoC study to evaluate the efficacy, safety, and tolerability of efzofitimod in patients with SSc-ILD. The primary ob...

25 participants
aTyr Pharma, Inc.
View Study Details

About Scleroderma Clinical Trials in Los Angeles

Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.

There are currently 4 scleroderma clinical trials recruiting participants in Los Angeles, CALIFORNIA. These studies are seeking a combined 1,031 participants. Research is being sponsored by Scleroderma Research Foundation, Inc., AstraZeneca, GlaxoSmithKline and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Scleroderma Clinical Trials in Los Angeles — FAQ

Are there scleroderma clinical trials in Los Angeles?

Yes, there are 4 scleroderma clinical trials currently recruiting in Los Angeles, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What scleroderma treatments are being tested?

The 4 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.

Data updated March 2, 2026 from ClinicalTrials.gov